Lysosomal and mitochondrial aging

There is 1 paper on lysosomal and mitochondrial aging in aging research: 1 observational study in people. The newest story, Nov 3, 2026: “Measures of aging in cell structures linked to disease risk”.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on lysosomal and mitochondrial aging

“APOE-{varepsilon}4 dosage was associated with lysosomal and mitochondrial aging and reduced PDP1 levels, implicating altered energy metabolism.”
Organelle Aging Predicts Human DiseasebioRxiv2026doi:10.64898/2026.11.01.763400
  • Humans1

Associations

1

APOE

mixedin humans1

1 study
  1. APOE is associated with lysosomal and mitochondrial aging in humans (APOE ε4 dosage).

    “APOE-{varepsilon}4 dosage was associated with lysosomal and mitochondrial aging and reduced PDP1 levels, implicating altered energy metabolism.”

    HumansAPOE ε4 dosage

    Measures of aging in cell structures linked to disease risk

    bioRxivPreprint

More on APOE

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
bioRxiv

Measures of aging in cell structures linked to disease risk

Among 61,931 people, four or more prematurely aged compartments were linked to up to 22-fold higher kidney disease risk and up to 8-fold higher mortality risk.Among 61,931 people, four or more prematurely aged compartments were linked to up to 22-fold higher kidney disease risk and up to 8-fold higher mortality risk.

Preprint: cohort study of 61,931 peopleBiomarkers